What is it about?
New regimens for DR-TB treatment are now available at a much lower cost than current treatments. These regimens are also more effective and patient friendly. Countries should prioritize use of these regimens implementation and scale up of BPaLM/BPaL regimens
Featured Image
Photo by Volodymyr Hryshchenko on Unsplash
Why is it important?
It is important to implement these regimens to save lives of DR-TB patients. In addition to this, it also saves money compared to current regimens. This money can be used to treat more TB patients in each country
Perspectives
I hope this article creates greater awareness of the cost savings and effectiveness of these regimens so countries can implement faster and save lives.
Aastha Gupta
TB Alliance
Read the Original
This page is a summary of: Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis, PLOS Global Public Health, November 2022, PLOS,
DOI: 10.1371/journal.pgph.0001287.
You can read the full text:
Contributors
The following have contributed to this page
